摘要
120例晚血患者随机分成2组,每组60人,治疗组接受安络化纤丸治疗,对照组接受常规护肝药物治疗,治疗12个月后,治疗组症状体征明显改善,肝纤维化指标下降。
A total of 120 patients with advanced schistosomiasis were divided into two groups. Group A （60 patients） were treated with Anluo Huaxian Wan. Group B （60 patients） were treated with routine liver protection drugs. After 12-month treatment, not only the symptoms and abnormal signs of the patients in Group A improved greatly, but also the level of markers of hepatic fibrosis reduced significantly.
出处
《中国血吸虫病防治杂志》
CAS
CSCD
北大核心
2011年第3期317-317,320,共2页
Chinese Journal of Schistosomiasis Control
关键词
晚期血吸虫病
肝纤维化
安络化纤丸
治疗效果
Advanced schistosomiasis
Hepatic fibrosis
Anluo Huaxian Wan
Therapeutic effect
